Overview
Esmolol in Cardiac Surgery
Status:
Completed
Completed
Trial end date:
2018-06-01
2018-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This large randomized double-blind clinical trial (esmolol vs placebo) will enroll patients undergoing cardiac surgery to study the additive cardiac protection of this therapeutic strategy.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Università Vita-Salute San RaffaeleTreatments:
Adrenergic beta-Antagonists
Esmolol
Criteria
Inclusion Criteria:- end diastolic diameter >60 mm and/or an ejection fraction <50%
- written informed consent
- age >18 years
Exclusion Criteria:
- previous unusual response to esmolol
- inclusion in other randomized studies
- esmolol administration in the previous 30 days
- emergency operation